does glp 1 cause muscle wasting matters: the effects of medically induced weight loss on skeletal muscle You might have heard that

Unfortunately, misinformation about these medications has also taken the Internet by storm

During the week of June 15, 2026, FDA issued 25 warning letters to telehealth companies over alleged false or misleading promotional claims about compounded GLP-1 productsclaims the agency views as violating the Federal Food, Drug, and Cosmetic Acts (FDCA) misbranding provisions, including Sections 502(a) and 502(n).

Herein, we highlight the key scientific advances in utilising incretins for the treatment of obesity and, potentially, non-alcoholic fatty liver disease (NAFLD)

Retatrutide works by activating GLP-1, GIP and glucagon receptors